Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 34, 2005 - Issue 2
225
Views
65
CrossRef citations to date
0
Altmetric
Original

Antitumor Activity and Underlying Mechanisms of Ganopoly, The Refined Polysaccharides Extracted from Ganoderma Lucidum, in Mice

, , , , , , , , , , & show all
Pages 171-198 | Published online: 07 Jul 2009

References

  • Agarwala, S S., Glaspy, J., O'Day, S J., Mitchell, M., Gutheil, J., Whitman, E., Gonzalez, R., Hersh, E., Feun, L., Belt, R., Meyskens, F., Hellstrand, K., Wood, D., Kirkwood, J M., Gehlsen, K R., Naredi, P. (2002). Results from a randomized Phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma. J. Clin. Oncol. 20:125–133. [PUBMED], [INFOTRIEVE]
  • Alsop, R M., Vlachogiannis, G J. (1982). Determination of the molecular weight of clinical dextrans by gel permeation chromatography on TSK PW type columns. J. Chromatogr. 246:227–240. [CROSSREF]
  • Bao, X F., Liu, C P., Fang, J N., Li, X Y. (2001). Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohyd. Res. 332:67–74. [CSA], [CROSSREF]
  • Bao, X F., Zhen, Y., Ruan, L., Fang, J N. (2002a). Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem. Pharm. Bull. 50:623–629. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Bao, X F., Wang, X S., Dong, Q., Fang, J N., Li, X Y. (2002b). Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59:175–181. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Battle, J., Ha, T Z., Li, C F., Dellabeffa, V., Rice, P., Kalbfleisch, J., Browder, W., Williams, D. (1998). Ligand binding to the (1-]3)-beta-d-glucan receptor stimulates NF-kappa B activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun. 249:499–504. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Brekhman, I. (1980). Man and Biological Active Substances. New York: Pergamon Press.
  • Brittenden, J., Heys, S D., Ross, J., Eremin, O. (1996). Natural killer cells and cancer. Cancer 77:1226–1243. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Burnet, F M. (1971). Immunological surveillance in neoplasia. Transplant. Rev. 7:3–13. [PUBMED], [INFOTRIEVE]
  • Cao, L Z., Lin, Z B. (2002). Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol. Lett. 83:163–169. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cao, L Z., Lin, Z B. (2003). Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta. Pharmacol. Sin. 24:321–326. [PUBMED], [INFOTRIEVE], [CSA]
  • Chang, S T., Mshigeni, K E. (2000). Ganoderma lucidum—Paramount among medicinal mushrooms. Discov. Innovat. 12:97–101.
  • Chen, J H., Jiang, R L. (1980). A pharmacological study of the Chinese drug lingzhi (Ganoderma). Acta. Pharmacol. Sin. 15:234–244.
  • Chen, T W., Wong, Y K., Lee, S S. (1991). In vitro cytotoxicity of Ganoderma lucidum on oral cancer cells. Chung Hua i Hsueh Tsa Chih—Chin. Med. J. (Chinese) 48:54–58.
  • Ching, L.-M., Browne, W L., Tchernegovski, R., Gregory, T., Baguley, B C., Palmer, B D. (1998). Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity. Br. J. Cancer 78:336–343., [PUBMED], [INFOTRIEVE]
  • Chung, K S., Kim, S B., Chung, S H. (1997). Immunoactivities of the protein-polysaccharides of the tips of the growing carpophores of Ganoderma lucidum. Yakhak Hoeji 41:105–110.
  • Cooper, M A., Fehniger, T A., Caligiuri, M A. (2001). The biology of human natural killer-cell subsets. Trend. Immunol. 22:633–640. [CSA], [CROSSREF]
  • Dische, Z. (1947). A new specific color reaction of hexuronic acids. J. Biol. Chem. 167:189–198.
  • Dubois, M., Gilles, K A., Hamilton, J K., Rebers, P A., Smith, F. (1956). Colorimetric method for determination of sugar and related substances. Anal. Chem. 28:350–356. [CROSSREF]
  • Fidler, I J., Ellis, L M. (2000). Chemotherapeutic drugs—more really is not better. Nat. Med. 6:500–502. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Furusawa, E., Chou, S C., Furusawa, S., Hirazum, A., Dang, Y. (1992). Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice. Phytother. Res. 6:300–304.
  • Gao, Y H., Zhou, S F. (2003). Cancer prevention and treatment by Ganoderma, a mushroom with medicinal properties. Food Rev. Int. 19:275–325. [CROSSREF]
  • Gao, J J., Min, B S., Ahn, E M., Nakamura, N., Lee, H K., Hattori, M. (2002a). New triterpene aldehydes, lucialdehydes A–C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem. Pharm. Bull. 50:837–840. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gao, Y H., Zhou, S F., Chen, G L., Dai, X H., Ye, J X. (2002b). A phase I/II study of a Ganoderma lucidum extract (Ganopoly) in patients with advanced cancer. Int. J. Med. Mushr. 4:207–214.
  • Gao, Y H., Zhou, S F., Huang, M., Lan, J., Gao, H. (2002c). Mechanisms for the protective effects of Ganoderma lucidum polysaccharide fraction on indomethacin-induced ulcer in the rat. Life Sci. 72:731–745. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gao, Y H., Zhou, S F., Jiang, W Q., Huang, M., X.H., D. (2003). Effect of Ganopoly, a Ganoderma lucidum polysaccharide extract on the immunological function in advanced-stage cancer patients. Immunol. Invest. 32:201–215. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Gibbs, J B. (2000). Mechanism-based target identification and drug discovery in cancer research. Science 287:1969–1973. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gong, Y J., Fei, X F., Gao, X X., Zhang, J., Wang, B X., Minami, M., Nagata, T., Ikejima, T. (2001). Effect of polysaccharide F III-2 from Ganoderma tsugae on proinflammatory cytokine production by THP-1 cells and human peripheral blood mononuclear cells. Zhonghua Yaolixue Yu Dulixue Zazhi—Chin. J. Pharmacol. Toxicol. 15:401–407.
  • Goto, S., Sato, M., Kaneko, R., Itoh, M., Sato, S., Takeuchi, S. (1999). Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol. Immunother. 48:435–442. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Greensfelder, L. (2000). Alternative medicine. Herbal product linked to cancer. Science 288:1946. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gupta, M., Majumdar, U K., Ray, M R., Mukhopadhayay, D K. (1997). Inhibition of experimental murine tumors by MT81, a new mycotoxin from Penicillium nigricans. Neoplasma 44:329–333., [PUBMED], [INFOTRIEVE], [CSA]
  • Haak-Frendscho, M., Kino, K., Sone, T., Jardieu, P. (1993). Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell. Immunol. 150:101–113. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Han, M D., Lee, E S., Kim, Y K., Lee, J W., Jeong, H., Yoon, K H. (1998). Production of nitric oxide in raw 264.7 macrophages treated with ganoderan, the beta-glucan of Ganoderma lucidum. Korean J. Mycol. 26:246–255.
  • Ho, J W., Leung, Y K., Chan, C P. (2002). Herbal medicine in the treatment of cancer. Curr. Med. Chem. Anti-Cancer Agents, 2:209–214. [CSA], [CROSSREF]
  • Hsu, M J., Lee, S S., Lin, W W. (2002). Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J. Leukoc. Biol. 72:207–216. [PUBMED], [INFOTRIEVE], [CSA]
  • Hsu, M J., Lee, S S., Lee, S T., Lin, W W. (2003). Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br. J. Pharmacol. 139:289–298. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R M., Aguet, M. (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259:1742–1745. [PUBMED], [INFOTRIEVE]
  • Hwang, S F., Liu, K J., Kuan, Y H., Tung, K S., Su, C H., Tung, T C. (1989). The inhibitory effect on artificial pulmonary metastasis of murine S-180 sarcoma cells by orally administered Ganoderma lucidum culture broth. J. Chin. Oncol. Soc. 5:10–15.
  • Ikekawa, T., Nakanishi, M., Uehara, N. (1968). Anti-tumor action of some basidiomycetes, especially Phellinus linteus. Jpn. J. Cancer Res. 59:155–157.
  • Jeong, K H., Park, W B., Kim, H W., Choi, E C., Kim, B K. (1992). Studies on antitumor components of the cultured mycelia of interspecific protoplast fusant F-2 of Ganoderma lucidum and Ganoderma applanatum. Korean J. Mycol. 20:324–336.
  • Jong, S C., Birmingham, J M. (1992). Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol. 37:101–134. [PUBMED], [INFOTRIEVE]
  • Jovic, V., Konjevic, G., Radulovic, S., Jelic, S., Spuzic, I. (2001). Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma. Tumori 87:324–329. [PUBMED], [INFOTRIEVE], [CSA]
  • Kempf, R A., Mitchell, M S. (1985). Effects of chemotherapeutic agents on the immune response. II. Cancer Invest. 3:23–33. [PUBMED], [INFOTRIEVE], [CSA]
  • Kim, R S., Kim, H W., Kim, B K. (1997). Suppressive effects of Ganoderma lucidum on proliferation of peripheral blood mononuclear cells. Mol. Cell. 7:52–57. [CSA]
  • Kino, K., Yamashita, A., Yamaoka, K., Watanabe, J., Tanaka, S., Ko, K., Shimizu, K., Tsunoo, H. (1989). Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J. Biol. Chem. 264:472–478. [PUBMED], [INFOTRIEVE]
  • Konopski, Z., Smedsrod, B., Seljelid, R., Eskeland, T. (1994). A novel immunomodulator soluble aminated β-1,3-d-glucan: binding characteristics to mouse peritoneal macrophages. Biochim. Biophys. Acta, Mol. Cell Res. 1221:61–65. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kubota, T., Takahara, T., Nagata, M., Furukawa, T., Kase, S., Tanino, H., Ishibiki, K., Kitajima, M. (1993). Colorimetric chemosensitivity testing using sulforhodamine B. J. Surg. Oncol. 52:83–88., [PUBMED], [INFOTRIEVE]
  • Laemmli, U K. (1970). Cleavage of structure proteins during the assembly of the head bacteriophage 14. Nature 227:680–685. [PUBMED], [INFOTRIEVE]
  • Lauerova, L., Dusek, L., Simickova, M., Kocak, I., Vagundova, M., Zaloudik, J., Kovarik, J. (2002). Malignant melanoma associates with Th1/Th2 imbalance that coincides with disease progression and immunotherapy response. Neoplasma 49:159–166. [PUBMED], [INFOTRIEVE], [CSA]
  • Lee, S S., Chen, F D., Chang, S C., Wei, Y H., Liu, I., Chen, C F., Wei, R D., Chen, K Y., Han, R W. (1984). In vivo anti-tumor effects of crude extracts from the mycelium of Ganoderma lucidum. J. Chin. Oncol. Soc. 5:22–28. [CSA]
  • Lee, J W., Chung, C H., Jeong, H., Lee, K H. (1990). Effects of alkali extract of Ganoderma lucidum IY007 on complement system. Korean J. Mycol. 18:137–144. [CSA]
  • Lee, S S., Wei, Y H., Chen, C F., Wang, S Y., Chen, K Y. (1995). Antitumor effects of Ganoderma lucidum. J. Chin. Med. 6:1–12.
  • Lee, Y S., Yang, H O., Shin, K H., Choi, H S., Jung, S H., Kim, Y M., Oh, D K., Linhardt, R J., Kim, Y S. (2003). Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica. Eur. J. Pharmacol. 465:191–198. [PUBMED], [INFOTRIEVE]
  • Li, M C., Lei, L S., Liang, D S., Xu, Z M., Yuan, J H., Yang, S Q., Sun, L S. (2000). Effect of Ganoderma lucidum polysaccharides on oxygen free radicals in murine peritoneal macrophages. Zhonghua Yaolixue Yu Dulixue Zazhi—Chin. J. Pharmacol. Toxicol. 14:65–68.
  • Lin, C N., Tome, W P., Won, S J. (1991). Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod. 54:998–1002. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lin, W H., Hung, C H., Hsu, C I., Lin, J Y.(1997). Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J. Biol. Chem. 272:20044–20048. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Lindsay, G K., Roslansky, P F., Novitsky, T J. (1989). Single-step, chromogenic Limulus amebocyte lysate assay for endotoxin. J. Clin. Microbiol. 27:947–951. [PUBMED], [INFOTRIEVE], [CSA]
  • Lippsmeyer, B C., Tracy, M L., Moller, G. (1990). Ion-exchange liquid chromatographic determination of nitrate and nitrite in biological fluids. J. Assoc. Off. Anal. Chem. 73:457–462. [PUBMED], [INFOTRIEVE]
  • Liu, G T. (1999a). Pharmacology and clinical application of the spores of Ganoderma lucidum (Curt:Fr.) P.Karst. and Mycelium of Ganoderma capense (Lloyd) Teng. (Aphyllophromycitideae). Int. J. Med. Mushr. 1:217–222.
  • Liu, G T. (1999b). Recent advances in research of pharmacology and clinical applications of Ganoderma P. Karst. species (Aphyllophoromycetideae) in China. Int. J. Med. Mushr. 1:63–67.
  • Mao, T., van De Water, J., Keen, C L., Stern, J S., Hackman, R., Gershwin, M E. (1999). Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int. J. Immunother. 15:13–22. [CSA]
  • Mihich, E., Fefer, A. (1983). Biological Response Modifiers: Subcommittee Report. Baltimore, MDUSA: NCI Monogr.
  • Min, B S., Gao, J J., Nakamura, N., Hattori, M. (2000). Triterpenes from the spores ofGanoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chem. Pharm. Bull. 48:1026–1033. [PUBMED], [INFOTRIEVE], [CSA]
  • Miyazaki, T., Nishijima, M. (1981). Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull. 29:3611–3616. [PUBMED], [INFOTRIEVE], [CSA]
  • Muller, A., Rice, P J., Ensley, H., Coogan, P S., Kalbfleisch, J H., Kelley, J L., Love, E J., Portera, C A., Ha, T Z., Browder, I W., Williams, D L. (1996). Receptor binding and internalization of a water-soluble (1-]3)-beta-d-glucan biologic response modifier in two monocyte macrophage cell lines. J. Immunol. 156:3418–3425. [PUBMED], [INFOTRIEVE]
  • Mueller, A., Raptis, J., Rice, P J., Kalbfleisch, J H., Stout, R D., Ensley, H E., Browder, W., Williams, D L. (2000). The influence of glucan polymer structure and solution conformation on binding to (1→3)-beta-d-glucan receptors in a human monocyte-like cell line. Glycobiology 10:339–346. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nemmani, K V., Jena, G B., Dey, C S., Kaul, C L., Ramarao, P. (2002). Cell proliferation and natural killer cell activity by polyherbal formulation. Immu-21 in mice. Indian J. Exp. Biol. 40:282–287. [PUBMED], [INFOTRIEVE], [CSA]
  • Nogami, M., Ito, M., Kubo, M., Takahashi, M., Kimura, H., Matsuike, Y. (1986a). Studies on Ganoderma lucidum. VII. Anti-allergic effect. Yakugaku Zasshi—J. Pharm. Soc., Jpn. 106:600–604. [CSA]
  • Nogami, M., Tsuji, Y., Kubo, M., Takahashi, M., Kimura, H., Matsuike, Y. (1986b). Studies on Ganoderma lucidum. VI. Anti-allergic effect. Yakugaku Zasshi—J. Pharm. Soc., Jpn. 106:594–599. [CSA]
  • Oh, J Y., Chung, K S. (1998). Flow cytometrical analysis of the antitumor and immunomodulatory activities of GLB-A and GLB-B, the protein-polysaccharide fractions of the growing tips of Ganoderma lucidum. Yakhak Hoeji 42:487–493. [CSA]
  • Oh, J Y., Cho, K J., Chung, S H., Kim, J H., Lillehoj, H S., Chung, K S. (1998). Activation of macrophages by GLB, a protein-polysaccharide of the growing tips of Ganoderma lucidum. Yakhak Hoeji 42:302–306. [CSA]
  • Ohno, N., Miura, N N., Sugawara, N., Tokunaka, K., Kirigaya, N., Yadomae, T. (1998). Immunomodulation by hot water and ethanol extracts of Ganoderma lucidum. Pharm. Pharmacol. Lett. 8:174–177. [CSA]
  • Panadero, A., Yin, M B., Voigt, W., Rustum, Y M. (1995). Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331. Oncol. Res. 7:73–81. [PUBMED], [INFOTRIEVE], [CSA]
  • Pang, J H., Cao, Z., Joseph, W R., Baguley, B C., Ching, L.-M. (1998). Antitumour activity of the novel immune modulator 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice lacking the interferon-gamma receptor. Eur. J. Cancer 34:1282–1289. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Provinciali, M., Di Stefano, G., Fabris, N. (1992). Improvement in the proliferative capacity and natural killer cell activity of murine spleen lymphocytes by thyrotropin. Int. J. Immunopharmacol. 14:865–870. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Robertson, M J., Ritz, J. (1990). Biology and clinical relevance of human natural killer cells. Blood 12:2421–2438.
  • Roth, R I., Levin, F C., Levin, J. (1990). Optimization of detection of bacterial endotoxin in plasma with the Limulus test. J. Lab. Clin. Med. 116:153–161., [PUBMED], [INFOTRIEVE]
  • Santin, A D., Hermonat, P L., Ravaggi, A., Bellone, S., Roman, J., Pecorelli, S., Cannon, M., Parham, G P. (2000). Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 48:997–1006. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Sasaki, T., Arai, Y., Ikekawa, T., Chihara, G., Fukuoka, F. (1971). Antitumor polysaccharides from some Polyporaceae, Ganoderma applanatum and Phellinus linteus. Chem. Pharm. Bull. 19:821–826. [PUBMED], [INFOTRIEVE]
  • Shiao, M S., Lee, K R., Lin, L J., Wang, C T. (1994). Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum. In: Rosen, R T., ed. Food Phytochemicals for Cancer Prevention. II: Teas, Spices, and Herbs. Washington: American Chemical Society, pp. 342–354.
  • Sliva, D. (2003). Ganoderma lucidum (Reishi) in cancer treatment. Integr. Cancer Ther. 2:358–364. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Smith, P K., Krohn, R I., Hermanson, G T., Mallia, A K., Garter, F H., Provenzano, M D., Fujimoto, E K., Goeke, N M., Olson, B J., Klenk, D C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76–85. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Sone, Y., Okuda, R., Wada, N., Kishida, E., Misaki, A. (1985). Structural and anti-tumor activities of polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agr. Biol. Chem. 49:2641–2653. [CSA]
  • Tang, W., Hemm, I., Bertram, B. (2003). Recent development of antitumor agents from chinese herbal medicines; part I. Low molecular compounds. Planta. Med. 69:97–108. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D.(2002). Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer 87:21–27. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • van der Hem, L G., van der Vliet, J A., Bocken, C F., Kino, K., Hoitsma, A J., Tax, W J. (1995). Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60:438–443. [PUBMED], [INFOTRIEVE], [CSA]
  • Vickers, A. (2002). Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 20:1069–1079. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Villegas, F R., Coca, S., Villarrubia, V G., Jimenez, R., Chillon, M J., Jareno, J., Zuil, M., Callol, L. (2002). Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 35:23–28. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wang, S Y., Hsu, M L., Hsu, H C., Tzeng, C H., Lee, S S., Shiao, M S., Ho, C K. (1997). The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer 70:699–705. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Wasser, S P., Weis, A L. (1999). Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol. 19:65–96. [PUBMED], [INFOTRIEVE], [CSA]
  • Werner, G H., Jolles, P. (1996). Immunostimulating agents—what next—a review of their present and potential medical applications. Eur. J. Biochem. 242:1–19. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Wollschlaeger, B A. (2003). Herbal medicine. N. Engl. J. Med. 348:1498–1501., [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Won, S J., Lin, M T., Wu, W L. (1992). Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice. Jpn. J. Pharmacol. 59:171–176. [PUBMED], [INFOTRIEVE], [CSA]
  • Wu, T S., Shi, L S., Kuo, S C. (2001). Cytotoxicity of Ganoderma lucidum triterpenes. J. Nat. Prod. 64:1121–1122. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Wu, J., Yin, M B., Hapke, G., Toth, K., Rustum, Y M. (2002). Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin. Mol. Pharmacol. 61:742–748. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Zhang, J S., Tang, Q J., Zimmerman-Kordmann, M., Reutter, W., Fan, H. (2002). Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum. Life Sci. 71:623–638. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zhang, Q H., Lin, Z B. (1999a). Study on antitumor activity and mechanism of Ganoderma polysaccharides B. Zhonghua Zhongxiyi Jehe Zazhi—Chin. J. Integr. Tradit. West. Med. 19:544–547.
  • Zhang, Q H., Lin, Z B. (1999b). The antitumor activity of Ganoderma lucidum(Curt:Fr.)P. Karst.(Ling Zhi) (Aphyllophoromycetideae polysaccharides is related to tumor necrosis factor and interferon. Int. J. Med. Mushr. 1:207–215.
  • Zhou, S F., Kestell, P., Baguley, B C., Paxton, J W. (2002). 5,6-Dimethylxanthenone-4-acetic acid: a novel biological response modifier for cancer therapy. Invest. New Drugs 20:281–295. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Zhu, H S., Yang, X L., Wang, L B., Zhao, D X., Chen, L. (2000). Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell. Biol. Toxicol. 16:201–206. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.